Enteric-coated aspirin: review shows similar inhibition of platelet aggregation to ordinary dispersible aspirin.
D001241:Aspirin / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000503:physiopathology / Q000517:prevention & control; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D018570:Risk Assessment; D013608:Tablets, Enteric-Coated
D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013608:Tablets, Enteric-Coated; D001241:Aspirin